JP2023511062A5 - - Google Patents

Info

Publication number
JP2023511062A5
JP2023511062A5 JP2022542394A JP2022542394A JP2023511062A5 JP 2023511062 A5 JP2023511062 A5 JP 2023511062A5 JP 2022542394 A JP2022542394 A JP 2022542394A JP 2022542394 A JP2022542394 A JP 2022542394A JP 2023511062 A5 JP2023511062 A5 JP 2023511062A5
Authority
JP
Japan
Application number
JP2022542394A
Other languages
Japanese (ja)
Other versions
JPWO2021151004A5 (https=
JP2023511062A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014770 external-priority patent/WO2021151004A1/en
Publication of JP2023511062A publication Critical patent/JP2023511062A/ja
Publication of JPWO2021151004A5 publication Critical patent/JPWO2021151004A5/ja
Publication of JP2023511062A5 publication Critical patent/JP2023511062A5/ja
Pending legal-status Critical Current

Links

JP2022542394A 2020-01-22 2021-01-22 遺伝子療法ベクターの形質導入を増加又は増強するための及び免疫グロブリンを除去又は低減するための組成物及び方法 Pending JP2023511062A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062964565P 2020-01-22 2020-01-22
US62/964,565 2020-01-22
PCT/US2021/014770 WO2021151004A1 (en) 2020-01-22 2021-01-22 Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins

Publications (3)

Publication Number Publication Date
JP2023511062A JP2023511062A (ja) 2023-03-16
JPWO2021151004A5 JPWO2021151004A5 (https=) 2024-01-16
JP2023511062A5 true JP2023511062A5 (https=) 2024-01-16

Family

ID=76992653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542394A Pending JP2023511062A (ja) 2020-01-22 2021-01-22 遺伝子療法ベクターの形質導入を増加又は増強するための及び免疫グロブリンを除去又は低減するための組成物及び方法

Country Status (15)

Country Link
US (1) US20230241247A1 (https=)
EP (1) EP4093436A4 (https=)
JP (1) JP2023511062A (https=)
KR (1) KR20220161268A (https=)
CN (1) CN115135343A (https=)
AU (1) AU2021211730A1 (https=)
BR (1) BR112022014264A2 (https=)
CA (1) CA3165025A1 (https=)
CL (1) CL2022001984A1 (https=)
CO (1) CO2022011195A2 (https=)
IL (2) IL325936A (https=)
MX (1) MX2022009065A (https=)
PE (1) PE20221780A1 (https=)
PH (1) PH12022551843A1 (https=)
WO (1) WO2021151004A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113660938A (zh) * 2019-01-30 2021-11-16 国立研究开发法人国立精神·神经医疗研究中心 核酸递送复合物
WO2023109928A1 (zh) * 2021-12-16 2023-06-22 上海宝济药业有限公司 抗免疫球蛋白降解酶酶切的Fc变体
JP2024547125A (ja) * 2021-12-22 2024-12-26 上海宝済薬業股▲ふん▼有限公司 免疫グロブリン分解酵素IdeEの変異体の用途
CN117126270B (zh) * 2023-10-25 2024-02-13 首都儿科研究所 一种2型人博卡病毒型别特异性抗体及其应用
WO2025178891A1 (en) * 2024-02-19 2025-08-28 The Trustees Of Columbia University In The City Of New York Targeting immunoglobulin for treating aging and metabolic diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200745163A (en) * 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
US10336825B2 (en) * 2014-04-30 2019-07-02 Hanall Biopharma Co., Ltd. Antibody binding to FcRn for treating autoimmune diseases
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
US20230220069A1 (en) * 2020-06-17 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of gene therapy patients

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
JP2023511062A5 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)